A broader strategy for osteoporosis interventions.

Area of Science:

• Gerontology
• Orthopedics
• Pharmacology

Background:

• Osteoporosis affects approximately 50% of postmenopausal women, leading to bone fractures.
• Current screening identifies only a small fraction of women who will experience fractures.
• Existing screening and intervention strategies for osteoporosis are insufficient.

Purpose of the Study:

• To evaluate the effectiveness of current osteoporosis screening and intervention strategies.
• To propose a more effective approach for reducing postmenopausal fractures.
• To reassess the clinical utility of bone mineral density criteria for osteoporosis treatment.

Main Methods:

• Analysis of data from large clinical trials on anti-fracture interventions.
• Comparison of fracture reduction in screened populations versus broader treatment groups.
• Evaluation of cost-effectiveness of proposed intervention strategies.

Main Results:

• Large screening trials failed to significantly decrease total fracture numbers.
• Anti-resorptive therapies, such as bisphosphonates, substantially reduced fractures, even in women not initially identified as high-risk.
• Current osteoporosis definitions based on bone density do not accurately predict fracture risk or guide treatment effectively.

Conclusions:

• Current osteoporosis screening and treatment guidelines are inadequate for preventing fractures in most postmenopausal women.
• Broader use of generic bisphosphonates, guided by age or general fracture risk, could effectively reduce overall fracture rates.
• A reappraisal of osteoporosis diagnosis and treatment criteria is necessary to improve patient outcomes and cost-effectiveness.